Inspire Medical Systems, Inc. (INSP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1233681,
    "name": "Inspire Medical Systems, Inc.",
    "stock_name": "Inspire Medical Systems, Inc.",
    "full_name": "Inspire Medical Systems, Inc.",
    "name_url": "stocks-analysis/inspire-medical-systems-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "95.27",
    "chg": -23,
    "chgp": "-19.45%",
    "dir": -1,
    "prev_price": "118.27",
    "mcapval": "2,470.93",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US4577301090",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "13.08 M",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/inspire-medical-systems-inc-1233681-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Inspire Medical Systems Experiences Revision in Stock Evaluation Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/inspire-medical-systems-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-3652088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InspireMedicalS_technicaldot_3652088.png",
        "date": "2025-10-28 15:44:53",
        "description": "Inspire Medical Systems, Inc. has experienced significant challenges, with its stock price declining nearly 60% over the past year, contrasting sharply with the S&P 500's positive performance. Technical indicators show mixed signals, reflecting ongoing difficulties and the need for strategic adjustments in the current market landscape."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-technically-bullish-or-bearish-3651471",
        "imagepath": "",
        "date": "2025-10-28 11:44:02",
        "description": "As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, as well as bearish readings from the KST and Bollinger Bands on both weekly and monthly time frames. The MACD shows a conflicting mildly bullish signal on the weekly but is bearish on the monthly, indicating weakness in the longer-term trend. Additionally, the stock has significantly underperformed the S&P 500, with a year-to-date return of -58.18% compared to the S&P 500's 15.47%...."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-technically-bullish-or-bearish-3647923",
        "imagepath": "",
        "date": "2025-10-27 11:55:12",
        "description": "As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish daily moving average, bearish weekly Bollinger Bands, and bearish KST across both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating some short-term strength that is overshadowed by longer-term weakness. The Dow Theory reflects a mildly bullish weekly stance but is also mildly bearish monthly. Overall, the bearish indicators dominate, suggesting a weak technical outlook. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-technically-bullish-or-bearish-3646457",
        "imagepath": "",
        "date": "2025-10-26 11:29:58",
        "description": "As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and a bearish outlook from the KST on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across different time frames. Additionally, the Bollinger Bands are bearish on the weekly and mildly bearish on the monthly. \n\nIn terms of performance, the company has significantly underperformed compared to the S&P 500, with a year-to-date return of -58.18% versus the S&P 500's 15.47%, and a one-year return of -60.31% compared to the S&P 500's 16.90%...."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-overvalued-or-undervalued-3637873",
        "imagepath": "",
        "date": "2025-10-21 12:10:39",
        "description": "As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current financial metrics. Key ratios include a P/E ratio of 60, an EV to EBITDA of 62.23, and a PEG ratio of 0.12, which suggests that the stock is priced high relative to its earnings growth potential.\n\nIn comparison to its peers, Inspire Medical Systems has a P/E ratio significantly higher than QIAGEN NV at 24.20 and Bio-Rad Laboratories, Inc. at 16.20, both of which are considered fair. Additionally, while Inspire's PEG ratio is low at 0.12, indicating potential undervaluation in terms of growth, the overall high valuation ratios suggest it is not justified at the current price level. Over the past year, Inspire Medical Systems has underperformed significantly, with a return of -60.44% compared to the S&P 500's 14.08%, reinforcing the notion th..."
      },
      {
        "title": "Inspire Medical Systems Experiences Revision in Stock Score Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/inspire-medical-systems-valuation-grade-downgraded-from-attractive-to-fair-amid-market-volatility-3641055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InspireMedicalS_valuationdot_3641055.png",
        "date": "2025-10-20 17:15:59",
        "description": "Inspire Medical Systems, Inc. has recently adjusted its valuation, with its stock price at $78.01. Over the past year, the company has faced significant challenges, reflected in a -60.44% return. Key financial metrics indicate a premium valuation, while its performance compared to peers presents a mixed picture."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-overvalued-or-undervalued-3634743",
        "imagepath": "",
        "date": "2025-10-20 12:27:58",
        "description": "As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued, particularly when considering its P/E ratio of 60, which is significantly higher than the peer average of 43.22 for similar companies. Additionally, the EV to EBITDA ratio stands at 62.23, again above the peer average, while the PEG ratio is notably low at 0.12, suggesting that growth expectations may not justify the current price.\n\nIn comparison to its peers, Penumbra, Inc. is categorized as very expensive with a P/E of 75.41, while QIAGEN NV is considered fair with a P/E of 24.20. This context highlights that Inspire's valuation metrics are relatively high compared to its peers. Furthermore, the stock has underperformed against the S&P 500, with a year-to-date return of -57.92% compared to the index's 13.30%, reinfo..."
      },
      {
        "title": "Is Inspire Medical Systems, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inspire-medical-systems-inc-overvalued-or-undervalued-3632281",
        "imagepath": "",
        "date": "2025-10-19 12:05:26",
        "description": "As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued, particularly when considering its high P/E ratio of 60, which significantly exceeds the peer average P/E of 43.22 for similar companies like Penumbra, Inc. and QIAGEN NV, which have P/E ratios of 75.41 and 24.20, respectively. Additionally, the EV to EBITDA ratio stands at 62.23, further indicating a premium valuation compared to its peers.\n\nInspire Medical's PEG ratio of 0.12 suggests potential growth relative to its price, but this is overshadowed by its steep valuation metrics. The company has underperformed against the S&P 500, with a year-to-date return of -57.92% compared to the S&P 500's 13.30%, reinforcing the notion that the stock may be overvalued in its current state...."
      },
      {
        "title": "Inspire Medical Systems Hits New 52-Week Low at $70.90",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/inspire-medical-systems-hits-new-52-week-low-at-7090-3588393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InspireMedicalS_priceRelatedfactors_3588393.png",
        "date": "2025-10-02 22:37:39",
        "description": "Inspire Medical Systems, Inc. has reached a new 52-week low, reflecting a challenging year with a significant performance decline. The company, with a market capitalization of USD 2,471 million, has a P/E ratio of 60.00 and a negative debt-to-equity ratio, indicating a unique financial structure."
      }
    ],
    "total": 17,
    "sid": "1233681",
    "stock_news_url": "https://www.marketsmojo.com/news/inspire-medical-systems-inc-1233681"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Inspire Medical Systems Experiences Revision in Stock Evaluation Amid Market Challenges

2025-10-28 15:44:53

Inspire Medical Systems, Inc. has experienced significant challenges, with its stock price declining nearly 60% over the past year, contrasting sharply with the S&P 500's positive performance. Technical indicators show mixed signals, reflecting ongoing difficulties and the need for strategic adjustments in the current market landscape.

Is Inspire Medical Systems, Inc. technically bullish or bearish?

2025-10-28 11:44:02

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, as well as bearish readings from the KST and Bollinger Bands on both weekly and monthly time frames. The MACD shows a conflicting mildly bullish signal on the weekly but is bearish on the monthly, indicating weakness in the longer-term trend. Additionally, the stock has significantly underperformed the S&P 500, with a year-to-date return of -58.18% compared to the S&P 500's 15.47%....

Is Inspire Medical Systems, Inc. technically bullish or bearish?

2025-10-27 11:55:12

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish daily moving average, bearish weekly Bollinger Bands, and bearish KST across both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating some short-term strength that is overshadowed by longer-term weakness. The Dow Theory reflects a mildly bullish weekly stance but is also mildly bearish monthly. Overall, the bearish indicators dominate, suggesting a weak technical outlook. Multi-period return data is not available for comparison with the S&P 500....

Is Inspire Medical Systems, Inc. technically bullish or bearish?

2025-10-26 11:29:58

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and a bearish outlook from the KST on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across different time frames. Additionally, the Bollinger Bands are bearish on the weekly and mildly bearish on the monthly. In terms of performance, the company has significantly underperformed compared to the S&P 500, with a year-to-date return of -58.18% versus the S&P 500's 15.47%, and a one-year return of -60.31% compared to the S&P 500's 16.90%....

Is Inspire Medical Systems, Inc. overvalued or undervalued?

2025-10-21 12:10:39

As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current financial metrics. Key ratios include a P/E ratio of 60, an EV to EBITDA of 62.23, and a PEG ratio of 0.12, which suggests that the stock is priced high relative to its earnings growth potential. In comparison to its peers, Inspire Medical Systems has a P/E ratio significantly higher than QIAGEN NV at 24.20 and Bio-Rad Laboratories, Inc. at 16.20, both of which are considered fair. Additionally, while Inspire's PEG ratio is low at 0.12, indicating potential undervaluation in terms of growth, the overall high valuation ratios suggest it is not justified at the current price level. Over the past year, Inspire Medical Systems has underperformed significantly, with a return of -60.44% compared to the S&P 500's 14.08%, reinforcing the notion th...

Inspire Medical Systems Experiences Revision in Stock Score Amid Market Challenges

2025-10-20 17:15:59

Inspire Medical Systems, Inc. has recently adjusted its valuation, with its stock price at $78.01. Over the past year, the company has faced significant challenges, reflected in a -60.44% return. Key financial metrics indicate a premium valuation, while its performance compared to peers presents a mixed picture.

Is Inspire Medical Systems, Inc. overvalued or undervalued?

2025-10-20 12:27:58

As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued, particularly when considering its P/E ratio of 60, which is significantly higher than the peer average of 43.22 for similar companies. Additionally, the EV to EBITDA ratio stands at 62.23, again above the peer average, while the PEG ratio is notably low at 0.12, suggesting that growth expectations may not justify the current price. In comparison to its peers, Penumbra, Inc. is categorized as very expensive with a P/E of 75.41, while QIAGEN NV is considered fair with a P/E of 24.20. This context highlights that Inspire's valuation metrics are relatively high compared to its peers. Furthermore, the stock has underperformed against the S&P 500, with a year-to-date return of -57.92% compared to the index's 13.30%, reinfo...

Is Inspire Medical Systems, Inc. overvalued or undervalued?

2025-10-19 12:05:26

As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued, particularly when considering its high P/E ratio of 60, which significantly exceeds the peer average P/E of 43.22 for similar companies like Penumbra, Inc. and QIAGEN NV, which have P/E ratios of 75.41 and 24.20, respectively. Additionally, the EV to EBITDA ratio stands at 62.23, further indicating a premium valuation compared to its peers. Inspire Medical's PEG ratio of 0.12 suggests potential growth relative to its price, but this is overshadowed by its steep valuation metrics. The company has underperformed against the S&P 500, with a year-to-date return of -57.92% compared to the S&P 500's 13.30%, reinforcing the notion that the stock may be overvalued in its current state....

Inspire Medical Systems Hits New 52-Week Low at $70.90

2025-10-02 22:37:39

Inspire Medical Systems, Inc. has reached a new 52-week low, reflecting a challenging year with a significant performance decline. The company, with a market capitalization of USD 2,471 million, has a P/E ratio of 60.00 and a negative debt-to-equity ratio, indicating a unique financial structure.

View All News